Mainz Biomed N.V. Ordinary Shares earnings per share and revenue
On 26 sept 2025, MYNZ reported earnings of -- USD per share (EPS) for Q2 25, -- the estimate of -2.44 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -2.04 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Preguntas frecuentes
What were Mainz Biomed N.V. Ordinary Shares's earnings and revenue for the latest quarter Q2 2025?
For Q2 2025, Mainz Biomed N.V. Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Mainz Biomed N.V. Ordinary Shares's Q2 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Mainz Biomed N.V. Ordinary Shares expected to report next?
The next earning report is scheduled for 30 mar 2026.
What are the forecasts for Mainz Biomed N.V. Ordinary Shares's next earnings report?
Based on 3
analistas, Mainz Biomed N.V. Ordinary Shares is expected to report EPS of -$2.04 and revenue of -- for Q4 2025.